BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18515259)

  • 21. Tumour control probability (TCP) for non-uniform activity distribution in radionuclide therapy.
    Uusijärvi H; Bernhardt P; Forssell-Aronsson E
    Phys Med Biol; 2008 Aug; 53(16):4369-81. PubMed ID: 18660558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-cell-based computer simulation of the oxygen-dependent tumour response to irradiation.
    Harting C; Peschke P; Borkenstein K; Karger CP
    Phys Med Biol; 2007 Aug; 52(16):4775-89. PubMed ID: 17671335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A mathematical approach for evaluating the influence of dose heterogeneity on TCP for prostate cancer brachytherapy treatment.
    Strigari L; Orlandini LC; Andriani I; d'Angelo A; Stefanacci M; Di Nallo AM; Benassi M
    Phys Med Biol; 2008 Sep; 53(18):5045-59. PubMed ID: 18723926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First BNCT treatment of a skin melanoma in Argentina: dosimetric analysis and clinical outcome.
    González SJ; Bonomi MR; Santa Cruz GA; Blaumann HR; Calzetta Larrieu OA; Menéndez P; Jiménez Rebagliati R; Longhino J; Feld DB; Dagrosa MA; Argerich C; Castiglia SG; Batistoni DA; Liberman SJ; Roth BM
    Appl Radiat Isot; 2004 Nov; 61(5):1101-5. PubMed ID: 15308199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
    Jones B
    J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro neutron irradiation of glioma and endothelial cultured cells.
    Menichetti L; Gaetano L; Zampolli A; Del Turco S; Ferrari C; Bortolussi S; Stella S; Altieri S; Salvadori PA; Cionini L
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S336-40. PubMed ID: 19410472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On cold spots in tumor subvolumes.
    Tomé WA; Fowler JF
    Med Phys; 2002 Jul; 29(7):1590-8. PubMed ID: 12148742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A proof that uniform dose gives the greatest TCP for fixed integral dose in the planning target volume.
    Webb S; Evans PM; Swindell W; Deasy JO
    Phys Med Biol; 1994 Nov; 39(11):2091-8. PubMed ID: 15560013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microdosimetric study for interpretation of outcomes from boron neutron capture therapy clinical trials.
    Nichols TL; Miller LF; Kabalka GW; Dudney TM
    Radiat Prot Dosimetry; 2007; 126(1-4):645-7. PubMed ID: 17576651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Viability of the EUD and TCP concepts as reliable dose indicators.
    Ebert MA
    Phys Med Biol; 2000 Feb; 45(2):441-57. PubMed ID: 10701514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A normal tissue dose response model of dynamic repair processes.
    Alber M; Belka C
    Phys Med Biol; 2006 Jan; 51(1):153-72. PubMed ID: 16357438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A free program for calculating EUD-based NTCP and TCP in external beam radiotherapy.
    Gay HA; Niemierko A
    Phys Med; 2007 Dec; 23(3-4):115-25. PubMed ID: 17825595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose response of the AIA rabbit stifle joint to boron neutron capture synovectomy.
    Shortkroff S; Binello E; Zhu X; Gierga D; Thornhill TS; Shefer RE; Jones AG; Yanch JC
    Nucl Med Biol; 2004 Jul; 31(5):663-70. PubMed ID: 15219286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose distribution and clinical response of glioblastoma treated with boron neutron capture therapy.
    Matsuda M; Yamamoto T; Kumada H; Nakai K; Shirakawa M; Tsurubuchi T; Matsumura A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S19-21. PubMed ID: 19375933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TCP and NTCP: a basic introduction.
    Baumann M; Petersen C
    Rays; 2005; 30(2):99-104. PubMed ID: 16294901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analytical investigation of the possibility of parameter invariant TCP-based radiation therapy plan ranking.
    Stavreva N; Nahum A; Markov K; Ruggieri R; Stavrev P
    Acta Oncol; 2010 Nov; 49(8):1324-33. PubMed ID: 20950227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Volume effect models in radiation therapy].
    Sakata S
    Gan No Rinsho; 1987 Oct; 33(13):1532-41. PubMed ID: 3694792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dose--response relation for rat spinal cord paralysis analyzed in terms of the effective size of the functional subunit.
    Adamus-Górka M; Mavroidis P; Brahme A; Lind BK
    Phys Med Biol; 2008 Nov; 53(22):6533-47. PubMed ID: 18978440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted radionuclide therapy: theoretical study of the relationship between tumour control probability and tumour radius for a 32P/33P radionuclide cocktail.
    Lechner A; Blaickner M; Gianolini S; Poljanc K; Aiginger H; Georg D
    Phys Med Biol; 2008 Apr; 53(7):1961-74. PubMed ID: 18354241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the dosimetric impact of non-exclusion of the rectum from the boost PTV in IMRT treatment plans for prostate cancer patients.
    Kassim I; Dirkx ML; Heijmen BJ
    Radiother Oncol; 2009 Jul; 92(1):62-7. PubMed ID: 19278745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.